ATE264386T1 - Verfahren zur rnase- und organische lösemitteln- freier reinigung von plasmid-dns durch tangentialfluss-filtration - Google Patents

Verfahren zur rnase- und organische lösemitteln- freier reinigung von plasmid-dns durch tangentialfluss-filtration

Info

Publication number
ATE264386T1
ATE264386T1 AT00948876T AT00948876T ATE264386T1 AT E264386 T1 ATE264386 T1 AT E264386T1 AT 00948876 T AT00948876 T AT 00948876T AT 00948876 T AT00948876 T AT 00948876T AT E264386 T1 ATE264386 T1 AT E264386T1
Authority
AT
Austria
Prior art keywords
plasmid dna
flow filtration
tangential flow
rnase
organic solvent
Prior art date
Application number
AT00948876T
Other languages
English (en)
Inventor
Michelle D Butler
Darien L Cohen
David Kahn
Marjorie E Winkler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE264386T1 publication Critical patent/ATE264386T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/894—Manufacture, treatment, or detection of nanostructure having step or means utilizing biological growth
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898—Enzymatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/91—Strengthening cell or tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/912—Cancer cell repair
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914—Protein engineering
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT00948876T 1999-07-23 2000-07-21 Verfahren zur rnase- und organische lösemitteln- freier reinigung von plasmid-dns durch tangentialfluss-filtration ATE264386T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14531699P 1999-07-23 1999-07-23
US16520699P 1999-11-12 1999-11-12
PCT/US2000/019963 WO2001007599A1 (en) 1999-07-23 2000-07-21 Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration

Publications (1)

Publication Number Publication Date
ATE264386T1 true ATE264386T1 (de) 2004-04-15

Family

ID=26842848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948876T ATE264386T1 (de) 1999-07-23 2000-07-21 Verfahren zur rnase- und organische lösemitteln- freier reinigung von plasmid-dns durch tangentialfluss-filtration

Country Status (18)

Country Link
US (1) US6313285B1 (de)
EP (1) EP1200578B1 (de)
JP (1) JP2003505077A (de)
KR (1) KR100669305B1 (de)
CN (1) CN1378592A (de)
AT (1) ATE264386T1 (de)
BR (1) BR0012627A (de)
CA (1) CA2378944A1 (de)
DE (1) DE60009912T2 (de)
DK (1) DK1200578T3 (de)
ES (1) ES2218185T3 (de)
HK (1) HK1048829A1 (de)
HU (1) HUP0202295A3 (de)
IL (1) IL147644A0 (de)
NZ (1) NZ516641A (de)
PL (1) PL364816A1 (de)
PT (1) PT1200578E (de)
WO (1) WO2001007599A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602414B2 (en) * 2000-03-30 2003-08-05 Formulations Pro Molecule separation device and method combining multiple filtration media
AU2001294890A1 (en) * 2000-09-25 2002-04-02 Board Of Regents, The University Of Texas System Pei: dna vector formulations for in vitro and in vivo gene delivery
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
GB0028361D0 (en) * 2000-11-21 2001-01-03 Glaxo Group Ltd Method of separating extra chromosomal dna from other cellular components
JP3547715B2 (ja) * 2001-03-06 2004-07-28 榮 新垣 ベクター精製用装置及び方法
GB0107634D0 (en) * 2001-03-27 2001-05-16 Fermentas Ab Nucleic acid purification
DE60330842D1 (de) 2002-01-28 2010-02-25 Ambion Inc Für den nachweis von nukleinsäuren kompetente biologische rohderivate
CA2498518A1 (en) 2002-09-13 2004-03-25 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
US8501402B2 (en) 2003-03-24 2013-08-06 Boehringer Ingelheim Rcv Gmbh & Co Kg Methods and devices for producing biomolecules
CN1283792C (zh) 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
SE0400490D0 (sv) 2004-02-26 2004-02-26 Amersham Biosciences Ab Plasmid purification
CN101310022B (zh) * 2005-01-31 2013-01-16 默沙东公司 大规模生产质粒dna的上游和下游纯化方法
US20080102493A1 (en) * 2006-06-29 2008-05-01 Millipore Corporation Isolation of RNA and DNA from a biological sample
US7964350B1 (en) 2007-05-18 2011-06-21 Applied Biosystems, Llc Sample preparation for in situ nucleic acid analysis
US20080300397A1 (en) * 2007-05-31 2008-12-04 Ge Healthcare Uk Limited Modified spin column for simple and rapid plasmid dna extraction
EP2088196A1 (de) 2008-02-08 2009-08-12 Boehringer Ingelheim RCV GmbH & Co KG Verfahren und Vorrichtungen zur Herstellung von Biomolekülen
WO2009129524A2 (en) * 2008-04-18 2009-10-22 The General Hospital Corporation High-throughput plasmid dna preparation
TWI469992B (zh) * 2008-08-28 2015-01-21 Baxter Int 濃縮剪切靈敏生物聚合物的方法
EP2955233A1 (de) * 2008-12-19 2015-12-16 Life Technologies Corporation Proteinase K Inhibitore, Verfahren und Zusammensetzungen davon
ME03091B (de) 2009-12-01 2019-01-20 Translate Bio Inc Ausgabe von mrna zur vermehrung von proteinen und enzymen bei humangenetischen erkrankungen
SG10201605328WA (en) 2011-04-01 2016-08-30 Emd Millipore Corp Nanofiber containing composite structures
PT2717893T (pt) 2011-06-08 2019-08-20 Translate Bio Inc Composições de nanopartículas lipídicas e métodos para transferência de arnm
US20150267192A1 (en) 2012-06-08 2015-09-24 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
CA2904151C (en) 2013-03-14 2023-09-12 Shire Human Genetic Therapies, Inc. Cftr mrna compositions and related methods and uses
KR20150128687A (ko) * 2013-03-14 2015-11-18 샤이어 휴먼 지네틱 테라피즈 인크. 메신저 rna의 정제 방법
CN103525866A (zh) * 2013-03-22 2014-01-22 人福医药集团股份公司 制备质粒的方法
EA201992208A1 (ru) 2013-10-22 2020-07-31 Транслейт Био, Инк. ЛЕЧЕНИЕ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
BR112016009014B1 (pt) 2013-10-22 2024-02-06 Translate Bio, Inc USO DE COMPOSIÇÃO COMPREENDENDO mRNA PARA DEFICIÊNCIA DE ARGININOSSUCINATO SINTETASE
DK178664B1 (en) * 2013-10-25 2016-10-24 Amphi Consult V Martin Hesselsøe Aps A system and a method for concentrating traces of tissue from aquatic organisms in a water sample and use thereof
WO2015093545A1 (ja) * 2013-12-18 2015-06-25 旭化成株式会社 乳汁中の大腸菌群を検出する方法
KR102739894B1 (ko) 2014-04-25 2024-12-05 샤이어 휴먼 지네틱 테라피즈 인크. 메신저 rna 의 정제 방법
SG10201911354UA (en) 2014-06-26 2020-02-27 Emd Millipore Corp Filter structure with enhanced dirt holding capacity
KR102206959B1 (ko) * 2015-04-17 2021-01-25 이엠디 밀리포어 코포레이션 접선방향 유동 여과 모드에서 작동되는 나노섬유 한외여과막을 사용하여 샘플에서 목적하는 생물학적 물질을 정제하는 방법
EP3294885B1 (de) 2015-05-08 2020-07-01 CureVac Real Estate GmbH Verfahren zur herstellung von rna
WO2016193206A1 (en) * 2015-05-29 2016-12-08 Curevac Ag A method for producing and purifying rna, comprising at least one step of tangential flow filtration
MX2019010155A (es) 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.
WO2018213476A1 (en) 2017-05-16 2018-11-22 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
JP7159308B2 (ja) 2017-07-21 2022-10-24 メルク・ミリポア・リミテッド ラテラルフローデバイスおよびこれを用いる試料中の検体を検出する方法
WO2020041793A1 (en) 2018-08-24 2020-02-27 Translate Bio, Inc. Methods for purification of messenger rna
MX2021005969A (es) 2018-11-21 2021-09-14 Translate Bio Inc Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128669A1 (de) * 1981-07-20 1983-02-03 Hoechst Ag, 6000 Frankfurt "plasmid p svh 1 und seine verwendung"
GB8600582D0 (en) 1986-01-10 1986-02-19 Ca Minister Nat Defence Purifying biological materials
AU605901B2 (en) 1987-09-11 1991-01-24 Ares Trading S.A. Purification process
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
CA2192342A1 (en) * 1994-07-15 1996-02-01 Ann L. Lee A method for large scale plasmid purification
US6011148A (en) 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
US5707812A (en) 1996-08-06 1998-01-13 Vical Incorporated Purification of plasmid DNA during column chromatography
EP0853123A1 (de) * 1997-01-10 1998-07-15 Roche Diagnostics GmbH Reinigung von DNA durch Cross-Flow-Filtration
WO1999011764A2 (en) * 1997-09-05 1999-03-11 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of recombinant aav vectors
SE9703532D0 (sv) 1997-09-30 1997-09-30 Pharmacia Biotech Ab A process for the purification of plasmid DNA
WO1999063076A1 (en) 1998-06-01 1999-12-09 The Immune Response Corporation Novel method of large scale plasmid purification
US6268492B1 (en) 1998-08-10 2001-07-31 Chiron Corporation Methods for purifying non-chromosomal nucleic acid molecules from cells

Also Published As

Publication number Publication date
HK1048829A1 (zh) 2003-04-17
ES2218185T3 (es) 2004-11-16
NZ516641A (en) 2003-07-25
DE60009912T2 (de) 2005-04-14
US6313285B1 (en) 2001-11-06
WO2001007599A1 (en) 2001-02-01
KR100669305B1 (ko) 2007-01-17
CA2378944A1 (en) 2001-02-01
PL364816A1 (en) 2004-12-13
EP1200578B1 (de) 2004-04-14
BR0012627A (pt) 2002-04-09
KR20020019123A (ko) 2002-03-09
PT1200578E (pt) 2004-08-31
IL147644A0 (en) 2002-08-14
EP1200578A1 (de) 2002-05-02
CN1378592A (zh) 2002-11-06
HUP0202295A3 (en) 2005-01-28
DE60009912D1 (de) 2004-05-19
HUP0202295A2 (en) 2002-10-28
JP2003505077A (ja) 2003-02-12
DK1200578T3 (da) 2004-07-26

Similar Documents

Publication Publication Date Title
ATE264386T1 (de) Verfahren zur rnase- und organische lösemitteln- freier reinigung von plasmid-dns durch tangentialfluss-filtration
US5972613A (en) Methods of nucleic acid isolation
ATE236183T1 (de) Verfahren zur reinigung von nukleinsäuren
DE69908795D1 (de) Verfahren zur isolierung von nukleinsäure und vorrichtung hierfür
ATE163043T1 (de) Reinigungsmethode und entsprechende vorrichtung
WO1998030685A3 (de) Reinigung oder/und konzentrierung von dna durch cross-flow-filtration, abtrennung von endotoxinen aus einer nucleinsäure-präparation
CA2501308A1 (en) Extraction of dna from biological samples
ATE247605T1 (de) Verfahren zum biologischen reinigen von abwasser
EP0517515A2 (de) Verfahren zur Reinigung von DNS
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
ATE343559T1 (de) Verfahren zur reinigung von aceton
JP2978518B2 (ja) ファージｄｎａの精製方法
GB0107634D0 (en) Nucleic acid purification
ES2196870T3 (es) Procedimiento para la purificacion o aislamiento de acidos nucleicos virales.
NO20063278L (no) Hurtigfremstilling av nukleinsyrer ved enzymatisk fordoyelse
AU2003288164A1 (en) Method for treating radioactive waste water
WO2003057720A3 (en) Recovery of biofilament proteins from biological fluids
ATE522544T1 (de) Verfahren zur gewinnung und reinigung von rekombinantem protein aus zellen
ATA189096A (de) Verfahren zur reinigung von o-phthaldialdehyd
Whitney et al. V. 4-Direct wastewater RNA capture and purification via the" Sewage, Salt, Silica and SARS-CoV-2 (4S)" method
ATE442369T1 (de) Verfahren zur aufreinigung von riboflavin
DE50012444D1 (de) Verfahren zur herstellung endotoxinfreier nukleinsäuren
BR9807061A (pt) Purificação de dna em uma centrìfuga de fluxo contìnuo
PT1102721E (pt) Processo e dispositivo para separar biomassa e agua
Ravetkar et al. Large scale processing of tetanus toxin from fermentation broth

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200578

Country of ref document: EP

REN Ceased due to non-payment of the annual fee